A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations

The requested reference [1d5b89d42819f3c0096f4f2781ebb835d6eab224] no longer exists in our database. It has been replaced by the current reference: [f6f43902fb9fb70a1ebd04c205a6ed2ae91fe06a]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to assess the rate and extent of absorption of JNJ-64041575 by measuring ALS-008112 plasma concentrations following administration of a single oral dose of JNJ-64041575 given as 2 new concept formulations (oral suspension and tablet) compared to their respective current formulations under fasted conditions and to assess the effect of food on the pharmacokinetics of the 2 new concept formulations under fed condition in healthy adult participants.
Epistemonikos ID: 81eea7fd0af618a354a474a93dea0ce381de2572
First added on: May 20, 2024